NCT03739268 - GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

September 3, 2020

Study Completion Date

September 1, 2021

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Sevelamer

Sevelamer powder dissolved in water 1,600 mg three times a day for 17 days

DRUG

Placebo

placebo powder dissolved in water 1,600 mg three times a day for 17 days

Trial Locations (1)

Steno Diabetes Center Copenhagen, Gentofte Hospital, Hellerup